Latest Period
n/a
Security Snapshot
Biodexa Pharmaceuticals Plc - Ordinary Shares, nominal value 0.00005 GBP per share (BDRX) Institutional Ownership
CUSIP: 59564R807
13F Institutional Holders and Ownership History from Q4 2024 to Q3 2025
Institutions Reporting
Shares (Excl. Options)
Price
$0.86
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Ordinary Shares, nominal value 0.00005 GBP per share
- Symbol
- BDRX on Nasdaq
- Shares outstanding
- 25,770,441,176
- SEC-reported price per share
- $0.86
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- BDRX - Biodexa Pharmaceuticals Plc - Ordinary Shares, nominal value 0.00005 GBP per share is tracked under CUSIP 59564R807.
- Latest finished 13F holder period is not available.
- 1 significant owner is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 4 to 0 between Q2 2025 and Q3 2025.
- SEC-reported value moved from $17,010 to $0.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Schedule 13D/G
Open SEC evidence
Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.
Security key
59564R807
Latest holder period
n/a
13F holders
13D/G owners
1
CIK / CUSIP context first
BDRX full holder history
Biodexa Pharmaceuticals Plc SEC filings
Biodexa Pharmaceuticals Plc company facts
Biodexa Pharmaceuticals Plc insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 59564R807:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
1
Security
BDRX
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| C/M CAPITAL PARTNERS, LP | 6.8% | $2,611,061,100 | +$2,611,061,100 | 1,752,390,000 | Jonathan Juchno | 20 May 2025 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
4
Latest
n/a
Rows shown
1-4 of 4